Epidermolysis Bullosa Market Analysis

In 2017, the total prevalent population of Epidermolysis Bullosa in 7MM was 41,509. The prevalent cases of Epidermolysis Bullosa in the United States was 26,104 in 2017, while the United Kingdom and Germany had 5,037 and 4,919 prevalent cases respectively.

The market size of Epidermolysis Bullosa in 7MM USD 2,283.40 million in 2017.

The key players in the Epidermolysis Bullosa Market includes Amryt Pharma, Abeona Therapeutics, Castle Creek Pharmaceuticals, RegeneRx, Krystal Biotech, Fibrocell Technologies, Castle Creek Pharmaceuticals, RHEACELL GmbH, Holostem Terapie Avanzate, StemRim, Shionogi, Menlo Therapeutics and Phoenix Tissue Repair.

For more detailed information on Epidermolysis Bullosa Market, visit:
https://www.delveinsight.com/report-store/epidermolysis-bullosa-market